Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Integral Diagnostics Ltd. ( (AU:IDX) ) has issued an update.
Integral Diagnostics Ltd. has announced that non-executive director Raelene Murphy has ceased to be a director of the company effective 31 March 2026. The filing discloses that Murphy held 49,945 fully paid ordinary shares in the company at the time of her departure, with no additional indirect securities or contract-based interests reported, indicating a straightforward exit for governance and disclosure purposes.
The most recent analyst rating on (AU:IDX) stock is a Hold with a A$2.50 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics Ltd. is an Australian healthcare company that operates diagnostic imaging services, providing radiology and related imaging solutions to hospitals, medical practitioners, and patients. The company focuses on delivering high-quality imaging services across its network of clinics and facilities, supporting clinical decision-making and patient care.
Average Trading Volume: 855,165
Technical Sentiment Signal: Sell
Current Market Cap: A$875.9M
See more data about IDX stock on TipRanks’ Stock Analysis page.